Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
Primary Purpose
Depressive Symptoms, Depression
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Sister Circle protocol
Sponsored by

About this trial
This is an interventional treatment trial for Depressive Symptoms focused on measuring Sister Circle, Black Women
Eligibility Criteria
Inclusion Criteria:
- Identify as Black or African American
- Identify as female
- Age 40 years and older
- Community-dwelling
- Self-report of experiencing depressive symptoms
- Ability to commit to the 8-week intervention
- Access to Zoom
- Speak and read English
Exclusion Criteria:
- Have a diagnosis of bipolar, but is not taking medication for the condition
- Experiencing psychosis
Sites / Locations
- University of California, Los Angeles
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Group 1 Intervention, Weeks 1-8
Group 2 Intervention, Weeks 9-16
Arm Description
During Weeks 1-8, Group 1 receives the Intervention and Group 2 receives no treatment.
During Weeks 9-16, Group 2 receives the Intervention and Group 1 receives no treatment.
Outcomes
Primary Outcome Measures
Recruitment, completion, and retention rates of participants
80 percent recruitment, 80 percent completion, and 75 percent retention
Assess Acceptability according to the Theoretical Framework of Acceptability
Qualitative assessment of Acceptability. The interview guide will be organized according to the constructs of the Theoretical Framework of Acceptability. Methodological conventions of qualitative description will be used to analyze the data.
Secondary Outcome Measures
Changes in Perceived Stress Scale (PSS) from baseline at 8 weeks and 16 weeks
Exploratory description of effect sizes
Changes in Positive and Negative Affect Schedule (PANAS) Scale from baseline at 8 weeks and 16 weeks
Exploratory description of effect sizes
Changes in Acceptance and Action Questionnaire II (AAQ-II) from baseline at 8 weeks and 16 weeks
Exploratory description of effect sizes
Full Information
NCT ID
NCT04837573
First Posted
March 29, 2021
Last Updated
October 17, 2023
Sponsor
Kia Skrine Jeffers, PhD, RN, PHN
1. Study Identification
Unique Protocol Identification Number
NCT04837573
Brief Title
Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
Official Title
Evaluating the Feasibility and Acceptability of a Therapeutically-Grounded Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
September 14, 2022 (Actual)
Primary Completion Date
April 2, 2023 (Actual)
Study Completion Date
April 2, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Kia Skrine Jeffers, PhD, RN, PHN
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the feasibility and acceptability of a protocol for middle- and older-aged Black women with depressive symptoms.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depressive Symptoms, Depression
Keywords
Sister Circle, Black Women
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group 1 Intervention, Weeks 1-8
Arm Type
Experimental
Arm Description
During Weeks 1-8, Group 1 receives the Intervention and Group 2 receives no treatment.
Arm Title
Group 2 Intervention, Weeks 9-16
Arm Type
Active Comparator
Arm Description
During Weeks 9-16, Group 2 receives the Intervention and Group 1 receives no treatment.
Intervention Type
Behavioral
Intervention Name(s)
Sister Circle protocol
Intervention Description
The intervention is an 8-week, therapeutically-informed protocol.
Primary Outcome Measure Information:
Title
Recruitment, completion, and retention rates of participants
Description
80 percent recruitment, 80 percent completion, and 75 percent retention
Time Frame
16 weeks
Title
Assess Acceptability according to the Theoretical Framework of Acceptability
Description
Qualitative assessment of Acceptability. The interview guide will be organized according to the constructs of the Theoretical Framework of Acceptability. Methodological conventions of qualitative description will be used to analyze the data.
Time Frame
16 weeks
Secondary Outcome Measure Information:
Title
Changes in Perceived Stress Scale (PSS) from baseline at 8 weeks and 16 weeks
Description
Exploratory description of effect sizes
Time Frame
baseline, 8 weeks, 16 weeks
Title
Changes in Positive and Negative Affect Schedule (PANAS) Scale from baseline at 8 weeks and 16 weeks
Description
Exploratory description of effect sizes
Time Frame
baseline, 8 weeks, 16 weeks
Title
Changes in Acceptance and Action Questionnaire II (AAQ-II) from baseline at 8 weeks and 16 weeks
Description
Exploratory description of effect sizes
Time Frame
baseline, 8 weeks, 16 weeks
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Self-identified females
Minimum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Identify as Black or African American
Identify as female
Age 40 years and older
Community-dwelling
Self-report of experiencing depressive symptoms
Ability to commit to the 8-week intervention
Access to Zoom
Speak and read English
Exclusion Criteria:
Have a diagnosis of bipolar, but is not taking medication for the condition
Experiencing psychosis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kia Skrine Jeffers, PhD, RN, PHN
Organizational Affiliation
University of California, Los Angeles
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, Los Angeles
City
Los Angeles
State/Province
California
ZIP/Postal Code
90095
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Feasibility & Acceptability of a Virtual Sister Circle Intervention for Black Women With Depressive Symptoms
We'll reach out to this number within 24 hrs